Dr. Ghyslain Mombo-Ngoma led a study in Gabon in which researchers gave a single-dose treatment combining an artemisinin with ...
In what experts are calling a breakthrough in the global fight against malaria, a new next-generation drug candidate — GanLum (ganaplacide/lumefantrine, KLU156) — has shown a 97% cure rate in Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback